{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "02022886",
    "licUnit": "1",
    "validDate": "2030-05-15 00:00:00.000",
    "issueDate": "2025-04-01 00:00:00.000",
    "oriIssueDate": "2000-05-15",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA00202288605",
    "prodNameC": "立普妥　膜衣錠10毫克",
    "prodNameE": "LIPITOR FILM-COATED TABLETS 10MG",
    "indicationsName": [
        "高膽固醇血症、高三酸甘油脂血症。對於臨床上沒有冠心病的第二型糖尿病病人，但是至少有任一其他冠心病危險因子，包括高血壓、視網膜病變、白蛋白尿、或吸煙，Lipitor適用於：降低心肌梗塞的風險、降低中風的風險。降低冠心病高危險群的心血管事件發生率。對於臨床上沒有冠心病的高血壓病人，但是至少有三個其他冠心病危險因子，包括第二型糖尿病、年紀大於等於55歲、微白蛋白尿或蛋白尿、吸煙、或第一等親在55歲(男性)或60歲(女性)前曾經發生冠心病事件，Lipitor適用於：降低心肌梗塞的風險、降低中風的風險、降低血管再造術與心絞痛的風險。"
    ],
    "does": "1116",
    "packageUnit": [
        {
            "packageSpec": "2-1000粒",
            "packageUnit": "89"
        }
    ],
    "medMCode": "06",
    "maMedCode": null,
    "medDCode": null,
    "mainCategory": null,
    "drBaseId": "D021B8BB-C7A3-4279-9E26-D01686EDEB1B",
    "subCategory": [],
    "ingredientsDesc": [
        "ATORVASTATIN CALCIUM (2:1) TRIHYDRATE"
    ],
    "restraintItemsCode": [
        "02 輸 入",
        "07 新藥監視",
        "52 依本署七七公告於國內進行臨床試驗且核定為新藥",
        "67 成品已完成元素不純物評估(Option 1、2a、2b)"
    ],
    "applicantName": "暉致醫藥股份有限公司",
    "applicantAddr": "臺北市信義區信義路５段7號27樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "manuImportDesc": "廠商未登錄資料",
    "licManuImport": "2",
    "factoryDtoList": [
        {
            "id": "04553841-8982-4C21-A72F-7A75E7B8940F",
            "factoryCode": "1",
            "factoryName": "VIATRIS PHARMACEUTICALS LLC",
            "factoryAddr": "KM. 1.9 ROAD 689, VEGA BAJA, PUERTO RICO 00693",
            "factoryCompanyAddr": "",
            "countryCode": "PR",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FPR0019100",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "53843DD2-7D75-455D-BEB4-F3C0573C6DEB",
            "factoryCode": "2",
            "factoryName": "久裕企業股份有限公司",
            "factoryAddr": "桃園市桃園區大林里興邦路43巷2之1號4樓、3樓、1樓A區",
            "factoryCompanyAddr": "",
            "countryCode": "TW",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "6605071926",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "396C3EB7-9437-4556-AC69-23DB93EC5740",
            "factoryCode": "2",
            "factoryName": "Pfizer Manufacturing Deutschland GmbH",
            "factoryAddr": "Mooswaldallee 1, 79108 Freiburg Im Breisgau, Germany",
            "factoryCompanyAddr": "",
            "countryCode": "DE",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FDE0247200",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "2406003130",
            "ingredientsName": "ATORVASTATIN CALCIUM (2:1) TRIHYDRATE",
            "ingredientsDesc": "ATORVASTATIN CALCIUM (2:1) TRIHYDRATE",
            "concentDesc": "",
            "concent": "10.850000",
            "concentUnit": "001",
            "seq": "0",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "C10AA05"
        }
    ],
    "udiInfoList": [],
    "licBaseId": "456DCBA2-8AD0-4DE5-BBA4-254988DA6ABE"
}